Though need more investigation and clinical trials to confirm, these findings suggested that inhibition of EGFR might be a valid therapeutic choice, supplementing routine treatments such as surgery and radiotherapy for MPNST patients. This evidence concerns the gene EGFR and malignant peripheral nerve sheath tumor.